Navigation Links
Small Study Suggests Milk, Soy Proteins Lower Blood Pressure Modestly
Date:7/18/2011

ight-week intervention, soy protein was associated with a 2 mm reduction in systolic blood pressure," He said. "Milk protein supplement was associated with a 2.3 mm reduction in blood pressure readings."

While the reduction wasn't large, He estimates it could lead to 6 percent fewer strokes, for instance, in the general population.

He believes the study is the first of its kind to find a benefit from milk and soy protein in blood pressure reduction.

Dr. Thomas Giles, president of the American Society of Hypertension Specialist Program and a past president of the organization, called the study results underwhelming.

"You couldn't possibly make any dietary changes based on this study," said Giles, who is also a professor of medicine at Tulane University School of Medicine.

Among the study's flaws, he said, was that the researchers did not measure blood pressure for 24 hours, using an ambulatory monitor.

Dr. Suzanne Steinbaum, a preventive cardiologist at Lenox Hill Hospital in New York City, said, "I think future studies need to be done," since the new study was fairly small and did not cover a long period of time. Still, she added, "It shows us the importance of diet and modifying risk factors."

Small changes could make a difference, Steinbaum said. She suggests replacing animal fat with soy protein -- such as substituting a veggie burger with soy protein for a hamburger with animal protein, at least occasionally.

He offers many suggestions for those who want to maintain a healthy blood pressure. "Control your weight," he said. "Don't smoke."

The DASH diet (Dietary Approaches to Stop Hypertension) is a reasonable eating plan, he said. He also advises monitoring pressure regularly.

He reports consulting for Novartis and Forest Laboratories, which make blood pressure-lowering medicines.

More information

To learn more about blood pressure control, visit the

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Patients at small, isolated, rural hospitals in US more likely to receive lower quality of care
2. Small, Rural Hospitals Provide a Lower Quality of Care: Study
3. Experimental Drug Bests Chemo in Non-Small Cell Lung Cancer Study
4. Sweating the small stuff: Early adversity, prior depression linked to high sensitivity to stress
5. Radionuclide treatment against small tumors and metastases
6. Less toxic combination of erlotinib and bevacizumab is effective non-small cell lung cancer patients
7. Mayo Clinic finds surgeon caseload, practice setting affect treatment of small kidney tumors
8. New Defibrillator Shows Promise in Small Study
9. Presenting cancer treatment options in small doses yields smarter choices
10. Small molecules inhibit growth of human tumor cells
11. Fish Oil Promising Against Postpartum Depression in Small Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The Muscular Dystrophy Association (MDA) and Jiffy Lube today announced ... campaign that will raise funds to help save and improve ... disease. , As part of the campaign, Jiffy ... through Sept. 1, 2014 to make a donation to MDA, ... fight for muscle health. Since 2012, Jiffy Lube has raised ...
(Date:7/22/2014)... 2014 The Restful Jaw Company announces ... Restful Jaw ®. The FDA-registered external device is clinically ... jaw pain, fatigue and soreness during dental procedures. As ... when patients do not need to take breaks or ... Jaw is a vital solution in helping more than ...
(Date:7/22/2014)... HealthDay Reporter MONDAY, July ... treat moderate-to-severe allergic asthma appears to offer relief to people ... new research suggests. The prescription drug -- omalizumab (Xolair) ... and Drug Administration approval earlier this year for that use. ... at a high dose for a six-month period it seems ...
(Date:7/22/2014)... 21, 2014) Investigators at the Cedars-Sinai Samuel ... multistep investigational treatment for one of the most ... advanced pancreatic cancer. , Locally advanced pancreatic ... solid tumor, with a cumulative five-year survival rate ... disease. Surgery is rarely an option for patients ...
(Date:7/22/2014)... 80 percent of all drug candidates in the ... therefore rejected early in the drug discovery process. ... material Upsalite, has great potential for development of ... findings could allow the pharma companies to open ... discarded due to solubility problems and try them ...
Breaking Medicine News(10 mins):Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 2Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 3Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 2Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 3Health News:Asthma Drug May Help Those With Chronic Hives 2Health News:Asthma Drug May Help Those With Chronic Hives 3Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 2Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 3Health News:Supermaterial gives rejected drugs a new chance 2
... that second twins born at term are at a higher ... than first twins. However, planned caesarean section may prevent such ... born in Scotland between 1995 and 1998. They found significantly ... second twins born at term. No deaths were recorded among ...
... is observed that women are more likely to experience non-specific ... shows that women are less likely to get prompt treatment ... for 'clotbusting' drugs must be given very rapidly if they ... suggest why there could be a delay in diagnosing stroke ...
... be a waste of time. It does little to reduce ... down by stretching was thought to reduce the risk// of ... out to be wrong, but the stretching habit stuck. It ... injury and improve performance”, comments physiotherapist Rob Herbert of the ...
... was observed that the valve helps patients with advanced esophagal ... is difficulty in swallowing. Unfortunately, the cancer is often well ... survival rates it is generally poor and quite often all ... comfortable as possible. ,Part of this involves inserting ...
... to a new research it is observed that a surgically ... The research focuses on draining cerebrospinal fluid. This type of ... procedure was no longer used// when there seemed to be ... Recent studies of this type of shunting on patients with ...
... a new drug may lower the need for blood ... drug, polymerized bovine hemoglobin (HBOC-201),// is delivered intravenously and ... structure of the HBOC-201 is smaller and more mobile ... effectively distribute oxygen throughout the body. ,The study, ...
Cached Medicine News:
(Date:7/22/2014)... 22, 2014 Elekta (NSE:EKTAb) and Royal ... Christie NHS Foundation Trust ( Manchester, UK ... whose mission is to develop the clinical value of ... system. Such a system would, in principle, improve the ... "The Christie was an essential participant ...
(Date:7/22/2014)... SAN DIEGO , July 22, 2014  Halozyme ... that it has resumed enrollment and dosing of patients ... PEGPH20 in patients with pancreatic cancer under the revised ... PEGPH20 is an investigational PEGylated form of Halozyme,s proprietary ... of tumors that accumulate hyaluronan. "Our ...
(Date:7/22/2014)...  Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. ... with the Icahn School of Medicine at ... ) to utilize its proprietary information and data package ... Niemann-Pick Type C Disease (NPC), a rare disease, mostly ... license also covers other diseases and disorders relying on ...
Breaking Medicine Technology:The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
... N.J., Nov. 4 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ... months ended September 30, 2009, ending the quarter with $67.5 ... million from December 31, 2008. In October 2009, we ... offering costs from an underwritten public offering of 4,945,000 shares ...
... , PARIS, Nov. 4 Alcatel-Lucent (Euronext Paris and ... TeleHealth Manager, a secure and reliable remote patient monitoring ... Drug Administration (FDA) for marketing in the United States. ... supports remote patient monitoring with an easily deployable ...
Cached Medicine Technology:Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 7Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 8Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 9Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 10Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 11Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 12Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 13Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results 14U.S. Food and Drug Administration Clears Alcatel-Lucent Remote Patient Monitoring Solution for Sale in the United States 2U.S. Food and Drug Administration Clears Alcatel-Lucent Remote Patient Monitoring Solution for Sale in the United States 3
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
... line has the right product for any ... from intubated patients to patients with tracheotomies. ... anesthesia and critical care applications., ,The ... for patients and staff members. This entire ...
... (HCH) capture the patient`s exhaled heat and ... gas. Small and compact, they are specially ... Depending on the tidal volume requirements, select ... ,The adult HCH is ideal for patient ...
... These hygroscopic condenser humidifiers (HCH) capture ... return them in the inspired gas. Small ... provide bacteriostatic and hygroscopic benefits. Depending on ... adult or small-volume model., ,The adult ...
Medicine Products: